stockrowCytokinetics, Incorporated (CYTK) vs Madrigal Pharmaceuticals, Inc. (MDGL)
- Cytokinetics, Incorporated CYTK 54.93 −1.12%
- Madrigal Pharmaceuticals, Inc. MDGL 394.16 −1.48%
Cytokinetics, Incorporated and Madrigal Pharmaceuticals, Inc. are both Biotechnology companies. Madrigal Pharmaceuticals, Inc. is the larger, with a market value of $9.3B against $7.7B — 1.2× the size. Madrigal Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 92.8% against 29.9%. Madrigal Pharmaceuticals, Inc. has the higher net margin (−10.9% vs −686.6%) and the lower return on invested capital (−1,480.3% vs 0.00%). Across the 16 metrics below, Madrigal Pharmaceuticals, Inc. leads on 11 and Cytokinetics, Incorporated on 5.
Valuation
Profitability
| Metric | CYTK | MDGL | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 90.96% | 65.16% |
| Operating margin | (625.15%) | (10.69%) | 0.00% |
| Net margin | (686.63%) | (10.89%) | 0.00% |
| Free cash flow margin | (519.53%) | (11.81%) | 0.00% |
| Return on equity | 184.71% | (24.82%) | (50.12%) |
| Return on assets | (47.70%) | (11.12%) | (45.60%) |
| Return on invested capital | 0.00% | (1,480.32%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack